A similar pattern was also present in individuals with PV positive for JAK2 mutation in the UKBB-MPN cohort, although the number of such individuals was small (n = 40) as the overall UKBB-PV cohort had much higher than expected rates of PV negative for JAK2 mutation. The gene discussed is JAK2; the disease is myeloproliferative disorder.